Francisco Silva, VP of Research and Development, 10% Owner at BioRestorative Therapies, Inc. (BRTX), bought 4,954 shares at $2.22 ($11K) on 2023-08-31, disclosed to the SEC on 2023-08-31.
Open-market purchase of $11k BRTX by VP of Research and Development, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Clearly above the average filing.
| Filing → |
| BRTX | BUY | 2022-11-21 | $2K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $3K | — | Filing → |
| BRTX | BUY | 2022-10-12 | $2K | — | Filing → |